SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 520.07 |
Enterprise Value ($M) | 961.99 |
Book Value ($M) | 270.80 |
Book Value / Share | 6.69 |
Price / Book | 1.92 |
NCAV ($M) | -115.32 |
NCAV / Share | -2.85 |
Price / NCAV | -4.51 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.02 |
Return on Assets (ROA) | 0.02 |
Return on Equity (ROE) | 0.06 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.60 |
Current Ratio | 3.12 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 586.59 |
Assets | 972.71 |
Liabilities | 701.90 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 977.89 |
Operating Income | 71.85 |
Net Income | 32.61 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 13.31 |
Cash from Investing | -74.02 |
Cash from Financing | 26.99 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | BFI Co., LLC | 49.90 | 0.00 | |
13G/A | Vanguard Group Inc | 8.84 | -23.87 | |
13G | Pzena Investment Management Llc | 9.80 | -2.57 | |
13G/A | BlackRock Inc. | 18.00 | 0.12 | |
13G | Brandes Investment Partners, Lp | 10.48 | 4.44 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
5,559 | 50,287 | 11.05 | |
16,460 | 112,227 | 14.67 | |
19,091 | 118,460 | 16.12 | |
9,800 | 92,682 | 10.57 | |
(click for more detail) |
Similar Companies | |
---|---|
OCS – Oculis Holding AG | OCUL – Ocular Therapeutix, Inc. |
OMER – Omeros Corporation | PROC – Procaps Group S.A. |
PTGX – Protagonist Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io